Munera C - Search Results

1

Identifying optimal dosage regimes under safety constraints: An application to long term opioid treatment of chronic pain.

Laber EB, Wu F, Munera C, Lipkovich I, Colucci S, Ripa S. Laber EB, et al. Among authors: munera c. Stat Med. 2018 Apr 30;37(9):1407-1418. doi: 10.1002/sim.7566. Epub 2018 Feb 21. Stat Med. 2018. PMID: 29468702 Free PMC article.

2

Buprenorphine transdermal delivery system in adults with persistent noncancer-related pain syndromes who require opioid therapy: a multicenter, 5-week run-in and randomized, double-blind maintenance-of-analgesia study.

Landau CJ, Carr WD, Razzetti AJ, Sessler NE, Munera C, Ripa SR. Landau CJ, et al. Among authors: munera c. Clin Ther. 2007 Oct;29(10):2179-93. doi: 10.1016/j.clinthera.2007.10.010. Clin Ther. 2007. PMID: 18042474 Clinical Trial.

3

Efficacy and safety of buprenorphine transdermal system (BTDS) for chronic moderate to severe low back pain: a randomized, double-blind study.

Steiner D, Munera C, Hale M, Ripa S, Landau C. Steiner D, et al. Among authors: munera c. J Pain. 2011 Nov;12(11):1163-73. doi: 10.1016/j.jpain.2011.06.003. Epub 2011 Jul 31. J Pain. 2011. PMID: 21807566 Free article. Clinical Trial.

4

Efficacy and safety of the seven-day buprenorphine transdermal system in opioid-naïve patients with moderate to severe chronic low back pain: an enriched, randomized, double-blind, placebo-controlled study.

Steiner DJ, Sitar S, Wen W, Sawyerr G, Munera C, Ripa SR, Landau C. Steiner DJ, et al. Among authors: munera c. J Pain Symptom Manage. 2011 Dec;42(6):903-17. doi: 10.1016/j.jpainsymman.2011.04.006. Epub 2011 Sep 25. J Pain Symptom Manage. 2011. PMID: 21945130 Free article. Clinical Trial.

5

Considerations for improving assay sensitivity in chronic pain clinical trials: IMMPACT recommendations.

Dworkin RH, Turk DC, Peirce-Sandner S, Burke LB, Farrar JT, Gilron I, Jensen MP, Katz NP, Raja SN, Rappaport BA, Rowbotham MC, Backonja MM, Baron R, Bellamy N, Bhagwagar Z, Costello A, Cowan P, Fang WC, Hertz S, Jay GW, Junor R, Kerns RD, Kerwin R, Kopecky EA, Lissin D, Malamut R, Markman JD, McDermott MP, Munera C, Porter L, Rauschkolb C, Rice ASC, Sampaio C, Skljarevski V, Sommerville K, Stacey BR, Steigerwald I, Tobias J, Trentacosti AM, Wasan AD, Wells GA, Williams J, Witter J, Ziegler D. Dworkin RH, et al. Among authors: munera c. Pain. 2012 Jun;153(6):1148-1158. doi: 10.1016/j.pain.2012.03.003. Epub 2012 Apr 9. Pain. 2012. PMID: 22494920

6

A Subgroup Analysis Found no Diminished Response to Buprenorphine Transdermal System Treatment for Chronic Low Back Pain Patients Classified with Depression.

Yarlas A, Miller K, Wen W, Lynch SY, Munera C, Dain B, Pergolizzi JV Jr, Raffa R, Ripa SR. Yarlas A, et al. Among authors: munera c. Pain Pract. 2016 Apr;16(4):473-85. doi: 10.1111/papr.12298. Epub 2015 Apr 11. Pain Pract. 2016. PMID: 25865734

7

A randomized, 14-day, double-blind study evaluating conversion from hydrocodone/acetaminophen (Vicodin) to buprenorphine transdermal system 10 μg/h or 20 μg/h in patients with osteoarthritis pain.

Ripa SR, McCarberg BH, Munera C, Wen W, Landau CJ. Ripa SR, et al. Among authors: munera c. Expert Opin Pharmacother. 2012 Jun;13(9):1229-41. doi: 10.1517/14656566.2012.667073. Epub 2012 Mar 12. Expert Opin Pharmacother. 2012. PMID: 22409388 Clinical Trial.

8

Dose-Dependent Flux of Buprenorphine Following Transdermal Administration in Healthy Subjects.

Wang Y, Cipriano A, Munera C, Harris SC. Wang Y, et al. Among authors: munera c. J Clin Pharmacol. 2016 Oct;56(10):1263-71. doi: 10.1002/jcph.718. Epub 2016 Mar 21. J Clin Pharmacol. 2016. PMID: 26865472 Clinical Trial.

9

A randomized, placebo-controlled, double-blinded, parallel-group, 5-week study of buprenorphine transdermal system in adults with osteoarthritis.

Munera C, Drehobl M, Sessler NE, Landau C. Munera C, et al. J Opioid Manag. 2010 May-Jun;6(3):193-202. doi: 10.5055/jom.2010.0017. J Opioid Manag. 2010. PMID: 20642248 Clinical Trial.

10

Application site adverse events associated with the buprenorphine transdermal system: a pooled analysis.

Wen W, Lynch SY, Munera C, Swanton R, Ripa SR, Maibach H. Wen W, et al. Among authors: munera c. Expert Opin Drug Saf. 2013 May;12(3):309-19. doi: 10.1517/14740338.2013.780025. Epub 2013 Mar 19. Expert Opin Drug Saf. 2013. PMID: 23506252

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

41 results

Search Page